Luteal Phase Defect: Clinical Trials

10 trials for Luteal Phase Defect, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 recruiting, 1 withdrawn. 3 Not applicable, 2 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 3
Phase 32Completed 1, Withdrawn 1
Phase 42Completed 1, Recruiting 1

Follow Luteal Phase Defect: new trials by email Literature Review of Luteal Phase Defect trials Research Report on Luteal Phase Defect

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment
Progesterone Vaginal Product, Placebo - Pregnancy Related, Fertility Issues
Phase 4RecruitingUMC Utrecht10082023-03-012025-12-31
Luteal Support in Frozen-Thawed Embryo Transfer Cycles
Dydrogesterone 10Mg Tablet (duphaston), Progesterone 50Mg/mL Oil, Crinone 8% Vaginal Gel - Implantation; Placenta, Pregnancy Loss
Phase 4CompletedCentrum Clinic IVF Center1512021-06-302022-01-11
Luteal Support in Artificial Vitrified/Warmed Cycles With Low Progesterone
Progesteron TID - IVF, Embryo Loss
Phase 3CompletedUniversity Hospital, Ghent872021-04-022026-03-23
Progesterone Levels and Clinical Outcomes Using a Single Pessary of 400 mg of Vaginal Progesterone in Substitutive Cycles for Embryo Transfer.
Vaginally administered progesterone - Luteal Phase Defect
CompletedInstituto Bernabeu3472021-03-032021-03-19
Luteal Phase Support In IVF Women Using GnRH Agonist
Decapeptyl 0.2mg - IVF, Luteal Phase Defect
CompletedNational University of Malaysia2222018-11-292019-11-25
Progesterone in Luteal Phase Deficiency
Progesterone, Placebo - Luteal Phase Defect
Phase 3WithdrawnIBSA Institut Biochimique SA2017-05-032017-12-06
Effects of Varied Estrogen Doses on Endometrial Receptivity
Luteal Phase Defect
CompletedReproductive Medicine Associates of New Jersey192015-03-012019-11-07
Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support
Oral dydrogesterone, Crinone 8% gel - Luteal Phase Defect
Not applicableCompletedUniversity of Zagreb8532010-10-012014-01-29
Bioenergetics of Exercise-Induced Menstrual Disturbances
Sedentary Control, Exercising control, 15 percent energy deficit - Menstruation Disturbances, Luteal Phase Defect
Not applicableCompletedPenn State University472001-05-012021-06-24
Energy Restriction and Hormones in Premenopausal Women
Exercise+CR, Light Conditioning - Menstruation Disturbances, Luteal Phase Defect
Not applicableCompletedPenn State University472001-03-012021-11-04

Narrower conditions

Menstruation Disturbances (2)  ·  Amenorrhea (1)  ·  Embryo Loss (1)  ·  Infertility (1)  ·  Oligomenorrhea (1)  ·  Pathologic Processes (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Pathologic Processes (2)  ·  Urogenital Diseases (2)  ·  Abortion, Spontaneous (1)  ·  Death (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Pregnancy Complications (1)

Interventions

Crinone (2)  ·  Dydrogesterone (2)  ·  Progesterone (2)  ·  Diet (1)  ·  Exercise (1)  ·  Gels (1)  ·  Oils (1)  ·  Tablets (1)  ·  Triptorelin Pamoate (1)  ·  Utrogestan (1)  ·  Vaginal Creams, Foams, and Jellies (1)

Sponsors

Penn State University (2)  ·  Centrum Clinic IVF Center (1)  ·  IBSA Institut Biochimique SA (1)  ·  Instituto Bernabeu (1)  ·  National University of Malaysia (1)  ·  Reproductive Medicine Associates of New Jersey (1)  ·  UMC Utrecht (1)  ·  University Hospital, Ghent (1)  ·  University of Zagreb (1)

Countries

Belgium (1)  ·  Croatia (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Emre Pabuccu, Assoc. Prof. (1)  ·  Jozo Tomic, M.D. (1)  ·  Muhammad Azrai Abu, Medical Degree (1)  ·  Nancy I Williams, ScD (1)  ·  Nancy Williams, ScD (1)  ·  Richard T Scott, MD, HCLD (1)  ·  Vlatka Tomic, M.D. (1)

Results publications

PMID 11473961, PMID 12202415, PMID 12909519, PMID 12970285, PMID 15070873, PMID 15890740, PMID 16556673, PMID 16926261, PMID 18192671, PMID 18320439, PMID 19797013, PMID 19909586, PMID 20159003, PMID 20334664, PMID 20605898, PMID 2161310, PMID 25160805, PMID 25238659, PMID 25352438, PMID 25456166, PMID 25622239, PMID 25927026, PMID 26568750, PMID 27761732, PMID 28228316, PMID 28663739, PMID 29023359, PMID 29040638, PMID 29338855, PMID 30304457, PMID 30700175, PMID 32613240, PMID 33340402, PMID 41263858, PMID 8458924

NIH funding

M01RR010732 (1), R01HD039245 (1)